- Home
- AZ vs RNAC Comparison
AZ vs RNAC Comparison
Compare AZ & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AZ | RNAC |
|---|---|---|
| Founded | 2018 | 2007 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 267.6M | 295.3M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | AZ | RNAC |
|---|---|---|
| Price | $5.65 | $8.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $15.00 | ★ $34.00 |
| AVG Volume (30 Days) | ★ 284.4K | 259.8K |
| Earning Date | 05-14-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,797,000.00 |
| Revenue This Year | $532.60 | N/A |
| Revenue Next Year | $178.94 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.97 | $5.60 |
| 52 Week High | $11.62 | $14.56 |
Technical Indicators
Market Signals| Indicator | AZ | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 45.42 | 43.32 |
| Support Level | $5.08 | $6.04 |
| Resistance Level | $6.67 | $9.27 |
| Average True Range (ATR) | 0.38 | 0.74 |
| MACD | 0.01 | -0.29 |
| Stochastic Oscillator | 33.88 | 6.69 |
Price Performance
Historical ComparisonAbout AZ A2Z Smart Technologies Corp.
A2Z Cust2Mate Solutions Corp is engaged in creating shopping carts. With the help of a user-friendly smart algorithm, touch screen, and other technologies, the company streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply pick & go, and bypass long cashier checkout lines.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.